Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vilsboll T – Preclinical studies have shown that both liraglutide and exenatide treatment can increase beta–cell mass, stimulate beta–cell proliferation, increase beta–cell neogenesis and inhibit beta–cell apoptosis. Clinical studies are needed to confirm these findings in humans. Replication of these data in humans could have important clinical implications for the treatment of type 2 diabetes.

   

Today in Basic Science/Genetics...keeping you current

Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease
Lipids in Health and Disease, 12/04/09

Targeting the RET Pathway in Thyroid Cancer
Clinical Cancer Research, 12/01/09

Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI
Diabetes, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address